Total Payments
$41,580
2024 Payments
$9,953
Companies
47
Transactions
955
Medicare Patients
2,813
Medicare Billing
$288,178
Payment Breakdown by Category
Other$18,250 (43.9%)
Food & Beverage$17,064 (41.0%)
Consulting$5,980 (14.4%)
Education$233.05 (0.6%)
Travel$52.41 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,250 | 13 | 43.9% |
| Food and Beverage | $17,064 | 921 | 41.0% |
| Consulting Fee | $5,980 | 6 | 14.4% |
| Education | $233.05 | 11 | 0.6% |
| Travel and Lodging | $52.41 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $19,722 | 60 | $0 (2024) |
| Dermavant Sciences, Inc. | $3,589 | 28 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,920 | 137 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,767 | 122 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $1,592 | 11 | $0 (2020) |
| ABBVIE INC. | $1,469 | 79 | $0 (2024) |
| Allergan, Inc. | $1,182 | 13 | $0 (2022) |
| Janssen Biotech, Inc. | $1,144 | 42 | $0 (2024) |
| GENZYME CORPORATION | $898.54 | 46 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $866.26 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,953 | 156 | Lilly USA, LLC ($3,692) |
| 2023 | $18,212 | 176 | Lilly USA, LLC ($15,668) |
| 2022 | $1,903 | 105 | Novartis Pharmaceuticals Corporation ($408.59) |
| 2021 | $1,381 | 82 | Novartis Pharmaceuticals Corporation ($301.11) |
| 2020 | $1,286 | 63 | MAYNE PHARMA INC. ($195.17) |
| 2019 | $2,287 | 123 | Medimetriks Pharmaceuticals, Inc. ($350.00) |
| 2018 | $2,450 | 142 | Galderma Laboratories, L.P. ($359.21) |
| 2017 | $4,108 | 108 | Medimetriks Pharmaceuticals, Inc. ($1,130) |
All Payment Transactions
955 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.23 | General |
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Inflammation | ||||||
| 12/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.07 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $113.77 | General |
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.14 | General |
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $40.76 | General |
| Category: Immunology | ||||||
| 11/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $119.49 | General |
| 11/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.63 | General |
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 931 | 1,906 | $207,849 | $95,307 |
| 2022 | 13 | 812 | 1,732 | $195,223 | $91,635 |
| 2021 | 12 | 619 | 1,316 | $135,500 | $64,317 |
| 2020 | 11 | 451 | 890 | $82,782 | $36,919 |
Total Patients
2,813
Total Services
5,844
Medicare Billing
$288,178
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 389 | $76,589 | $36,240 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 117 | 117 | $30,158 | $11,907 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 162 | $22,672 | $10,796 | 47.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 89 | 115 | $20,343 | $9,871 | 48.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 55 | 147 | $13,079 | $6,229 | 47.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 37 | 48 | $12,665 | $6,174 | 48.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 64 | 66 | $10,420 | $4,557 | 43.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $8,348 | $3,844 | 46.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 60 | 79 | $8,210 | $3,171 | 38.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 44 | 239 | $2,466 | $1,271 | 51.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $1,568 | $585.10 | 37.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 66 | 456 | $759.00 | $376.24 | 49.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 26 | $572.00 | $285.20 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 374 | $74,860 | $36,434 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 116 | 116 | $30,260 | $13,592 | 44.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 81 | 120 | $21,600 | $10,484 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 129 | $18,366 | $8,674 | 47.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 47 | 131 | $11,625 | $5,304 | 45.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 27 | 34 | $9,044 | $4,412 | 48.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 51 | 60 | $9,780 | $4,291 | 43.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $6,825 | $2,946 | 43.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 55 | 67 | $7,102 | $2,476 | 34.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 38 | 248 | $2,654 | $1,381 | 52.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 13 | 25 | $2,025 | $1,081 | 53.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 59 | 369 | $642.00 | $322.68 | 50.3% |
About Dr. Adaeze Egesi, M.D
Dr. Adaeze Egesi, M.D is a Dermatology healthcare provider based in Humble, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982929006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adaeze Egesi, M.D has received a total of $41,580 in payments from pharmaceutical and medical device companies, with $9,953 received in 2024. These payments were reported across 955 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,250).
As a Medicare-enrolled provider, Egesi has provided services to 2,813 Medicare beneficiaries, totaling 5,844 services with total Medicare billing of $288,178. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Humble, TX
- Active Since 03/31/2010
- Last Updated 08/12/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1982929006
Products in Payments
- OLUMIANT (Drug) $18,406
- VTAMA (Drug) $3,589
- DUPIXENT (Biological) $1,386
- Neo-Synalar Cream (Drug) $1,199
- COSENTYX (Biological) $1,190
- TREMFYA (Drug) $941.26
- EUCRISA (Drug) $660.51
- TALTZ (Drug) $618.97
- SKYRIZI (Biological) $611.35
- COSENTYX (Drug) $527.79
- DORYX (Drug) $509.25
- Trianex (Drug) $370.89
- EPIDUO FORTE (Drug) $360.54
- Sotyktu (Drug) $329.79
- ORACEA (Drug) $325.95
- Humira (Biological) $324.17
- Impoyz (Drug) $308.78
- Otezla (Drug) $305.96
- Zoryve (Drug) $298.40
- RINVOQ (Biological) $265.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.